ELTX — Elicio Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

Annual balance sheet for Elicio Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	34.6	88.8	50.5	12.9	17.6
Net Total Receivables	5	0.806	0	0.173	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	42.3	91.2	51.4	16.3	20.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.23	4.44	0.425	7.28	6.19
Long Term Investments
Other Long Term Assets
Total Assets	47.3	96.5	52.8	27.1	28.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	107	11.3	6.37	9.77	11.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	138	15	9.02	15.8	39.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-90.4	81.5	43.8	11.4	-11.3
Total Liabilities & Shareholders' Equity	47.3	96.5	52.8	27.1	28.2
Total Common Shares Outstanding